BOKU | IBSE

Congratulations on the successful habilitation Nico Lingg! 🎉🎓 What an impressive achievement! This milestone not only showcases your dedication and hard work, but also your passion for research and teaching. 🌟 The habilitation is a major step in any academic career, and a clear testament to your expertise and commitment to advancing knowledge. 📚💡 We are wishing you continued success in the years ahead, with groundbreaking research, exciting opportunities, and inspiring collaborations! 🚀🔬 We as an Institute are so proud of you!!! <3 #Habilitation #AcademicCareer #Research #Success #Science #Passion #Milestone

🌟 New Research Spotlight! 🌟 We are thrilled to announce a groundbreaking publication from researchers at IBSE, in collaboration with our esteemed partners: 🔬 Boehringer Ingelheim 🎓 Universität Innsbruck 🧬 Institute of Molecular Modeling & Simulation (IMMS) at University of Natural Resources and Life Sciences, Vienna (BOKU) Our work delves into the innovative CASPON® technology, paving the way for next-generation solutions in biomanufacturing. Published in Separation and Purification Technology, this study highlights transformative insights into scar-free tag removal and its broad applications. 📖 Don’t miss out—read the full paper here: https://lnkd.in/dQiQv_EP #Biotechnology #Innovation #CASPON #ResearchCollaboration

𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗩𝗮𝗰𝗰𝗶𝗻𝗲 𝗣𝗹𝗮𝘁𝗳𝗼𝗿𝗺𝘀 𝗧𝗵𝗿𝗼𝘂𝗴𝗵 𝗣𝗿𝗼𝗰𝗲𝘀𝘀 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 🦋 🐛 During my PhD, I was working with insect cells and the baculovirus vector expression system to produce virus-like particles - a promising platform for (not only) vaccine development. This work resulted in two publications: 1️⃣ Developing a resource-efficient production process for baculovirus, scalable for large-scale applications. 2️⃣ Purifying enveloped particles, such as baculoviruses, using non-woven fibers - a novel approach to address the challenges of bionanoparticle purification. 🧪 Purification remains one of the most demanding aspects of vaccine development, but innovative methods like non-woven fibers can open new possibilities for the field. 👩🔬 👨🔬 A huge thank you to my colleagues and Co-authors Patrícia, Nico, Peter, Miriam, Alois, Tobias, Magdalena, Osamah and Martina for their invaluable contributions and collaboration! 📄 You can read the full paper here: https://lnkd.in/d9iW8EVM ✨ Stay tuned for the upcoming manuscript! 🏠 Next stop: 𝟯𝗗 𝗣𝗿𝗶𝗻𝘁𝗶𝗻𝗴 𝗶𝗻 𝗕𝗶𝗼𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆

´Next generation bioprocess devlopment` at the esib 2024 https://www.esib.at/

🌟 Celebrating Excellence in Science! 🌟 We are thrilled to announce that two of our outstanding young scientists, Lisa Fohler and Fernando De Mathia, have been recognized for their exceptional contributions at the recent ESIB conference! 🏆 Lisa secured First Place in the Sustainability Science Flash Session category. Lisa presented her cutting-edge work on developing an optimized and scalable process to produce highly active PET-degrading enzymes, PHL7 and PHL7mut3, using E. coli. Her research offers a transformative solution for enzymatic recycling of PET plastic waste, enabling sustainable and cost-effective circular economy approaches without the need for costly purification steps. 🏆 Fernando won the award for Best Poster in the Biopharmaceutical category, presenting the poster "Purification and characterization of recombinant neuraminidase for non-seasonal vaccine against Influenza virus." We extend our heartfelt gratitude to the organizers of ESIB, acib GmbH, and the generous sponsors, Sandoz and the Computational and Structural Biotechnology Journal, for their support and recognition of our talented scientists. Congratulations to Lisa and Fernando for their well-deserved achievements! #ScienceExcellence #Sustainability #BioPharmaceuticals #ProudMoment #ESIB #acib #Sandoz #CSBJ #YoungScientists #Innovation

🌟 Exciting News from the SPICA conference 2024 in Milan! 🌟 We had a successful presence at the conference, showcasing the innovative work of our institute. A special shoutout to David Scheich, who was crowned the winner of the Slam presentations! 🎉 Additionally, Markus Berg, representing the ECOnti consortium, secured the second-place award for his poster. 🏆 Congratulations to both of you! We are proud to have such talented researchers in our ranks. Keep up the great work! 👏

Check out the latest publication from Markus Berg and co-authors!

🔬 Excited to announce the publication of our recent research in Biochemical Engineering Journal! 📄 Title: Streamlining Process Development and Scale-Up: Risk Assessment to Reduce Workload in Primary Protein Recovery This collaborative effort between researchers from BOKU | IBSE, acib GmbH and Boehringer Ingelheim RCV focuses on optimizing process development for primary recovery of biopharmaceuticals produced in Escherichia coli. Some key highlights: - Risk assessment is a critical tool for ensuring efficiency in biopharmaceutical production, from early development through to scale-up and tech transfer. - Comparative analysis between microscale bead milling and high-pressure homogenization. - The combination of risk assessment, microscale experiments, and miniaturized pressure flow curves provides an efficient approach to process development and scale-up in the recovery of proteins. A big thank you to all the amazing collaborators involved in this study! 🎉 Please follow the link for further information: https://lnkd.in/dUfxrJMM

👏 BOKU Innovator*innen im Rampenlicht: Im Rahmen des Forschungsservice-Open House überreichte Vizerektor Christian Obinger die Preise für die BOKU Erfindung 2024, die BOKU Erfinderin 2024 und das BOKU Start-up 2024. 🏆 Monika Cserjan ist die BOKU Erfinderin 2024! Bei der Ehrung betont VR Obinger die herausragende Leistung von Frau Cserjan, denn trotz ihrer Drittmittelanstellung zählt sie mit 6 Erfindungsmeldungen, 4 Patentanmeldungen und über 50 Publikationen zu den erfolgreichsten BOKU Forscherinnen. Frau Cserjan ist stark in die Ausbildung der nächsten Generation an Wissenschaftler*innen involviert und eignet sich durch ihre innovativen Forschungsleistungen hervorragend als BOKU Role Model. 🏆 Der Preis „BOKU Erfindung 2024“ ging an die BOKU Erfinder*innen Bernhard Scharf und Christina Henöckl vom Department für Bautechnik und Naturgefahren mit der Erfindung „StreetTree - Eine Anordnung zur begrünten Retention von Niederschlagswasser“ STREET-TREE-Planter ist ein neuartiges Konzept, um eine durchdachte und kostengünstige Möglichkeit zu schaffen, Stadtbäume noch einfacher und breiter als wirksame Maßnahme zur Klimawandelanpassung im urbanen Raum einzusetzen 🏆 Die Novasign GmbH erhielt den Preis „BOKU Start-up 2024“. Novasign konzentriert sich auf die Beschleunigung der Bioprozessentwicklung mit hybriden Modellierungslösungen und Software. Durch den Einsatz fortschrittlicher Tools für maschinelles Lernen wird eine erhebliche Verkürzung der Entwicklungszeiten für Bioprozesse sowohl für neue Pharmazeutika als auch für Biosimilars erreicht. Wir gratulieren den Preisträger*innen!

🚨 TRANSVAC Academy - Applications Now Open! 🚨 Are you looking to advance your knowledge and skills in #vaccine development? The #TRANSVACacademy is now accepting applications for its upcoming training courses! 🧪 Available Courses: - Vaccine Process Development and Scale-up - University of Natural Resources and Life Sciences, Vienna (BOKU) - Statistics for Preclinical Vaccine Research - BPRC  - Statistics for Vaccine Clinical Trials - BPRC 💡 Why apply? - Renowned experienced instructors & interactive learning environment - Networking opportunities with leading experts 🎯 Who can apply? - Researchers, professionals and students in vaccine R&D fields from academia, SMEs & industry. 🌎 Scholarships for LMIC Applicants:  - CEPI (Coalition for Epidemic Preparedness Innovations)-funded scholarships are provided to selected applicants. 🔗 Apply today! ➡ https://lnkd.in/devdPAH7 📅 Deadline: 21 October 2024 (23:59 CET) #TRANSVACAcademy #CareerGrowth #TRANSVAC #VaccineDevelopment #statistics